Portfolio (Quarterly)
Guide ↗
Privium Fund Management B.V.
· CIK 0001795097| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | AMZN | AMAZON COM INC | Consumer Cyclical | 125,000.0 | $26.0M | 5.42% | +4K | +3.3% | $208.27 | +17.3% |
| 2 | IONS | IONIS PHARMACEUTICALS INC | Healthcare | 290,024.0 | $21.8M | 4.53% | +49K | +20.4% | $75.09 | -1.3% |
| 3 | LMND | LEMONADE INC | Financial Services | 255,259.0 | $16.0M | 3.33% | +7K | +2.8% | $62.68 | -6.1% |
| 4 | AMD | ADVANCED MICRO DEVICES INC | Technology | 62,000.0 | $12.6M | 2.63% | +2K | +3.3% | $203.43 | +164.2% |
| 5 | IREN | IREN LIMITED | Financial Services | 320,150.0 | $11.0M | 2.29% | +40K | +14.3% | $34.28 | +74.9% |
| 6 | AXSM | AXSOME THERAPEUTICS INC. | Healthcare | 58,729.0 | $9.9M | 2.07% | +2K | +3.2% | $169.02 | +48.2% |
| 7 | PRQR | PROQR THRAPEUTICS N V | Healthcare | 5,467,149.0 | $8.9M | 1.84% | +109K | +2.0% | $1.62 | +16.7% |
| 8 | QURE | UNIQURE NV | Healthcare | 486,520.0 | $8.0M | 1.66% | +70K | +16.9% | $16.35 | +183.1% |
| 9 | RARE | ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 364,802.0 | $7.6M | 1.59% | +7K | +2.0% | $20.95 | +31.0% |
| 10 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | Healthcare | 320,972.0 | $7.6M | 1.57% | +15K | +4.9% | $23.56 | +11.2% |
| 11 | VRTX | VERTEX PHARMACEUTICALS INC | Healthcare | 11,355.0 | $5.1M | 1.06% | +2K | +21.4% | $446.54 | +2.8% |
| 12 | URGN | UROGEN PHARMA LTD | Healthcare | 238,122.0 | $4.3M | 0.89% | +24K | +10.9% | $17.98 | +86.7% |
| 13 | MGTX | MEIRAGTX HLDGS PLC | Healthcare | 212,112.0 | $1.8M | 0.38% | +12K | +6.1% | $8.66 | +30.7% |
| 14 | WVE | WAVE LIFE SCIENCES LTD | Healthcare | 241,010.0 | $1.7M | 0.36% | +48K | +24.9% | $7.25 | -17.9% |
| 15 | PFE | PFIZER INC | Healthcare | 52,679.0 | $1.5M | 0.31% | +15K | +39.5% | $28.08 | -10.2% |
| 16 | LXEO | LEXEO THERAPEUTICS INC | Healthcare | 205,000.0 | $1.2M | 0.24% | +12K | +6.5% | $5.74 | -14.1% |
| 17 | RNAC | CARTESIAN THERAPEUTICS INC | Healthcare | 179,114.0 | $1.1M | 0.23% | +7K | +3.8% | $6.15 | +56.6% |
| 18 | SRPT | SAREPTA THERAPEUTICS INC | Healthcare | 46,000.0 | $1.0M | 0.21% | +3K | +7.0% | $21.76 | -19.4% |
| 19 | RCKT | ROCKET PHARMACEUTICALS INC | Healthcare | 242,146.0 | $867K | 0.18% | +72K | +42.3% | $3.58 | -6.4% |
| 20 | TSHA | TAYSHA GENE THERAPIES INC | Healthcare | 181,900.0 | $813K | 0.17% | +17K | +10.3% | $4.47 | +43.6% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
33.5%
Consumer Cyclical
25.1%
Technology
24.3%
Financial Services
8.5%
Communication Services
6.8%
Energy
0.8%
Consumer Defensive
0.6%
Basic Materials
0.3%